Vytrus Biotech, S.A. (BME:VYT)
Spain · Delayed Price · Currency is EUR 5.95
0.00 (0.00%)
Last updated: Oct 7, 2025, 11:00 AM CET
Vytrus Biotech Market Cap
Vytrus Biotech has a market cap or net worth of €44.77 million as of October 7, 2025. Its market cap has increased by 170.63% in one year.
Market Cap
44.77M
Enterprise Value
44.01M
Revenue
6.09M
Ranking
n/a
PE Ratio
43.85
Stock Price
€5.95
Market Cap Chart
Since March 15, 2022, Vytrus Biotech's market cap has increased from 15.37M to 44.77M, an increase of 191.30%. That is a compound annual growth rate of 34.98%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 6, 2025 | 44.77M | 174.86% |
| Dec 31, 2024 | 16.29M | 29.02% |
| Dec 29, 2023 | 12.62M | -46.26% |
| Dec 30, 2022 | 23.49M | 52.86% |
| Mar 15, 2022 | 15.37M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Grifols | 7.27B |
| Laboratorios Farmaceuticos Rovi | 3.13B |
| Almirall | 2.56B |
| Pharma Mar | 1.61B |
| Faes Farma | 1.36B |
| Clínica Baviera | 672.29M |
| Laboratorio Reig Jofre | 259.64M |
| Oryzon Genomics | 255.88M |